Geode Capital Management’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.13M Buy
577,190
+62,303
+12% +$338K ﹤0.01% 2966
2025
Q1
$1.79M Buy
514,887
+33,028
+7% +$115K ﹤0.01% 3083
2024
Q4
$4.96M Buy
481,859
+41,537
+9% +$428K ﹤0.01% 2752
2024
Q3
$5.97M Buy
440,322
+7,845
+2% +$106K ﹤0.01% 2671
2024
Q2
$5.62M Buy
432,477
+32,409
+8% +$421K ﹤0.01% 2661
2024
Q1
$3.78M Sell
400,068
-625
-0.2% -$5.9K ﹤0.01% 2852
2023
Q4
$4.4M Buy
400,693
+39,538
+11% +$434K ﹤0.01% 2770
2023
Q3
$2.31M Buy
361,155
+44,480
+14% +$284K ﹤0.01% 3026
2023
Q2
$1.52M Buy
316,675
+72,483
+30% +$349K ﹤0.01% 3198
2023
Q1
$1.01M Buy
244,192
+13,582
+6% +$56K ﹤0.01% 3344
2022
Q4
$991K Buy
+230,610
New +$991K ﹤0.01% 3340